ROCKET PHARMACEUTICALS, INC. (RCKT) has 15 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 7 sales totalling $432K. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | Wilson Martin General Counsel | −$256,464 | 75,364 | −11% | No | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 18, 2026 | Wilson Martin General Counsel | −$2,133 | 631 | −0% | No | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 18, 2026 | Shah Gaurav CEO | −$7,753 | 2,293 | −0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 13, 2026 | Shah Gaurav CEO | −$9,592 | 2,837 | −0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 13, 2026 | Wilson Martin General Counsel | −$11,810 | 3,493 | −1% | No | |
|
|
||||||
Showing the 5 most recent of 15 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free